Certus International   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Bedford New Hampshire United States (1995)

Organization Overview

First Clinical Trial
2009
NCT00988936
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Certus International, Inc. | President, Certus International | President, Certus International Inc. Medical Monitor

Active Ingredients

Drugs in Phase 3 Trials (2)

technetium-99m bicisate (2 trials)

xenon xe-133 (2 trials)

Drugs in Phase 2 Trials (2)

hx4 (1 trial)

rgd-k5 (2 trials)

Drugs in Phase 1 Trials (1)

cp-18 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Carotid Stenosis (Phase 2)

Constriction, Pathologic (Phase 2)

Embolism (Phase 3)

Head and Neck Neoplasms (Phase 2)

Pulmonary Embolism (Phase 3)

Rectal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 5